Related by context. All words. (Click for frequent words.) 84 FDA Clears 82 Receives FDA Clearance 82 Completes Enrollment 79 Receives Orphan Drug Designation 79 Submits NDA 79 Shows Promise 78 FDA Approval 78 Receives Approvable Letter 78 Completes Patient Enrollment 77 FDA Accepts 77 PRN FDA Approves 77 Drug Candidate 77 Announces FDA Clearance 77 FDA Okays 76 Investigational Compound 75 Receives Positive Opinion 75 FDA Warns 75 Osteoporosis Drug 75 Obtains FDA 75 Presents Positive 75 Clinical Trial Evaluating 75 Improves Survival 75 Phase III Trial 75 Files IND 75 Mylan Receives Approval 74 Single Dose 74 Demonstrates Significant 74 IND Application 74 Receives Tentative Approval 74 Generic Versions 74 Generic Version 74 Meets Primary Endpoint 74 Phase IIb Trial 74 Phase III Clinical Trial 74 Initiates Phase II 74 Improves Outcomes 74 Blood Thinner 73 Increases Risk 73 Reduces Risk 73 Submits Biologics License Application 73 Initiates Clinical Trial 73 Submits Supplemental 73 Drug Shows Promise 73 Announces Tentative Approval 73 FDA Approvals 73 Gets FDA Clearance 73 Clinical Trial Results 73 Reports Positive 73 Patients Treated 73 Significantly Reduces 73 Initiates Clinical Trials 73 Receives Approval 73 Study Confirms 73 Drug Fails 73 Announces Initiation 73 Patent Issued 73 Significantly Reduced 73 Enrolls First 72 Initiates Phase 72 Receives Patent 72 Patients Treated With 72 Study Showed 72 Shows Promising 72 Study Demonstrates 72 FDA Panel Recommends 72 Effectively Treats 72 Develop Novel 72 Cholesterol Lowering Drug 72 Arthritis Drug 72 Sign Licensing Agreement 72 Study Evaluating 72 Gets Approval 72 Receives Milestone Payment 71 Adjunctive Therapy 71 Proves Effective 71 Present Preclinical Data 71 Granted Orphan Drug 71 Initiates Phase III 71 Extended Release 71 Trial Evaluating 71 Blood Pressure Drug 71 Previously Treated 71 Announce License Agreement 71 Demonstrates Positive 71 Submits Application 71 Pivotal Study 71 Diet Pill 71 Helps Prevent 71 Well Tolerated 71 Begins Shipping 71 k Clearance 71 Epilepsy Drug 71 Demonstrates Potential 71 Phase 2b Clinical Trial 71 Protects Against 71 Initiates Enrollment 71 Cholesterol Drug 71 Transdermal Patch 71 Adjuvant Treatment 71 FDA Clearance 71 Expanded Indication 71 Combination Treatment 71 Announces Publication 71 Lupus Drug 70 Prolongs Survival 70 Holds Promise 70 Announces Positive 70 Effective Than 70 Initiates Clinical 70 Recall Issued 70 Panel Backs 70 Generic Version Of 70 NDA Submission 70 Discontinues 70 Awarded Patent 70 Reveals Positive 70 Proven Effective 70 Presents Preclinical Data 70 Initiate Phase III 70 Significantly Improves 70 Prostate Cancer Vaccine 70 Phase 2b Trial 70 Commercialize 70 Advanced Melanoma 70 Patient Enrollment 70 Psoriasis Drug 70 Announce Collaboration 70 Investigational Treatment 69 Receives SFDA Approval 69 Sign License Agreement 69 Announces Availability 69 Obtains Approval 69 Appears Safe 69 Patent Covering 69 Low Dose 69 Begins Dosing 69 Resubmits 69 Combination Therapy 69 Launches Generic Version 69 Receives CE 69 Successfully Completes 69 Gout Drug 69 Increased Risk 69 Investigational Oral 69 Clinical Study Shows 69 Weight Loss Pill 69 Data Suggest 69 Achieves Milestone 69 Receives Fast Track 69 Patients Undergoing 69 Monotherapy 69 Migraine Drug 69 Initiate Clinical Trial 69 Introduces 69 Is Well Tolerated 69 CDC Recommends 69 Commercializes 69 Submits 69 Seeks Approval 69 Phase IIa Clinical Trial 69 Achieves Primary Endpoint 69 Phase IIb Clinical Trial 69 BioSante Pharmaceuticals Announces 69 Protease Inhibitor 69 Patients Enrolled 69 Preclinical Data 69 Receives Orphan Drug 69 Shows Efficacy 69 Study Suggests 69 Study Proves 69 FDA Approves Drug 69 Licenses Novel 69 Long Term Efficacy 69 Initiates Dosing 69 Shows Promise Against 69 Clinical Study 69 Announce Agreement 69 Demonstrated Significant 69 Taro Receives 68 Postmenopausal Osteoporosis 68 NICE Recommends 68 Announces License Agreement 68 Commences Phase 68 Signs Licensing Agreement 68 Previously Untreated 68 Successfully Treated 68 Wins Approval 68 Breast Cancer Patients 68 Study Indicates 68 Proves Successful 68 Introduces Revolutionary 68 Announces Voluntary Recall 68 Medoxomil 68 Recall Expanded 68 Vitrasert R 68 Begins Shipment 68 Study Links 68 Receives Positive 68 Pediatric Patients 68 Complicated Skin 68 Vaginal Gel 68 Scientists Develop 68 Drug Resistant 68 Pivotal Phase III 68 Recommends Approval 68 Antiviral Drugs 68 Study Shows 68 Spectrum Pharmaceuticals Announces 68 Submits IND 68 Files Investigational 68 FDA APPROVES 68 Oral Contraceptive 68 Novel Oral 68 Positive Opinion 68 Phase 2a Trial 68 Collaborators Present 68 Files Patent 68 Launches Innovative 68 Bird Flu Vaccine 68 Study Examines 68 Rheumatoid Arthritis Drug 68 Treatment Experienced 68 Hypertensive Patients 68 Obtains 68 AnaSpec Introduces 68 Acquires Exclusive 68 Inhibits 68 Demonstrates Long Term 68 Reduces Pain 68 ORLive Presents 68 Receives Complete Response 68 Announces Launch 68 Versus Placebo 68 Treatment Reduces 68 Hepatitis C Patients 68 Schizophrenia Drug 68 Therapy Improves 68 Receives Order 68 Successfully Completes Phase 68 Induces 68 Pooled Analysis 68 Cholesterol Drugs 67 Inhaled Insulin 67 Enter Into 67 Epilepsy Drugs 67 Announce Licensing Agreement 67 Elderly Patients 67 Pivotal Trial 67 Introduces Next Generation 67 Significantly Improved 67 Shingles Vaccine 67 Treatment Naive 67 Controlled Study 67 Demonstrates Efficacy 67 Milestone Payment 67 Being Studied 67 Osteoporosis Treatment 67 Cervical Cancer Vaccine 67 Announces Successful Completion 67 FDA Approves Generic 67 Panel Rejects 67 Drug Combo 67 Announces Presentation 67 Commonly Prescribed 67 Osteoporosis Drugs 67 Test Detects 67 Newly Diagnosed Multiple Myeloma 67 Breast Cancer Recurrence 67 Teva Provides Update 67 Postmenopausal Women 67 Lowers Risk 67 HER2 Positive 67 Unanimously Recommends Approval 67 Enters Agreement 67 Testosterone Gel 67 Pain Relievers 67 Successfully Tests 67 Phase 2a Clinical Trial 67 Cold Medicines 67 Drug Maker 67 Anti Inflammatory 67 Prostate Cancer Patients 67 Announce Availability 67 Submits Response 67 FDA Warns Against 67 Anemia Drugs 67 Receives Tentative FDA 67 Supplemental Biologics License Application 67 Heart Stents 67 Initiate Phase 67 STERIS Corporation Announces 67 Successfully Completed 67 Treatment Naïve Patients 67 Patients Suffering 67 Antidepressant Drug 67 Advanced Prostate Cancer 67 Receives Clearance 67 markets COLAZAL 67 Receives Notice 67 Abuse Resistant 67 Expand Collaboration 67 II Clinical Trial 67 Presents Positive Preclinical 67 Monoclonal Antibody 67 Hepatitis B Vaccine 67 Obtains License 67 Revolutionizes 67 Suppresses 67 Desvenlafaxine Succinate 67 Plus Ribavirin 67 Slow Progression 67 Jointly Develop 67 Oral Calcitonin 67 Vaccine Adjuvant 67 Sagent Pharmaceuticals Announces 66 Smallpox Vaccine 66 Can Detect 66 Deaths Linked 66 Launches 66 Treatment Resistant 66 Successfully Treats 66 Demonstrates Potent 66 Announces Completion 66 ANDA Filing 66 Ethinyl Estradiol 66 Receives Regulatory 66 Announces Commencement 66 Pivotal Phase 66 Survival Benefit 66 SABER ™ 66 Antitumor Activity 66 Lung Cancer Drug 66 Presents Preclinical 66 Inhaled Corticosteroids 66 Completes Dosing 66 Rolls Out 66 Gets Tentative 66 Investigational Agent 66 Recalled Due 66 Seasonal Influenza Vaccine 66 Beta Blocker 66 Provides Guidance 66 Drug Coated Stent 66 Panel Recommends 66 Commonly Used 66 Anemia Drug 66 Metastatic Colorectal Cancer 66 Treating Chronic 66 Fixed Dose 66 Glucose Control 66 Pharmacokinetic Study 66 Fungal Infections 66 Announces Licensing Agreement 66 Rat Poison Found 66 Rotavirus Vaccine 66 Commence Phase 66 Files Patent Application 66 Develop Next Generation 66 Voluntarily Withdraws 66 Patients Receiving 66 Release Capsules 66 Announce Collaboration Agreement 66 Signs License Agreement 66 Novartis Novo Nordisk 66 Fast Track Status 66 Significantly Increases 66 Chronic Hepatitis B 66 Mesalamine 66 Attains 66 Randomized Double Blind 66 Genes Linked 66 Lanthanum Carbonate 66 Receptor Agonist 66 Viagra Soft Cialis Soft 66 Severe Sepsis 66 Initiates Voluntary Recall 66 Heart Failure Patients 66 BioElectronics Announces 66 gets USFDA nod 66 Announces Issuance 66 Weight Loss Drug 66 JAK2 Inhibitor 66 Unveils 66 Cough Suppressant 66 Researchers Identify 66 Showed Significant 66 Announces Receipt 66 TNF Blockers 66 Progresses 66 Mg Uk 66 Novel Treatments 66 Advanced Colorectal Cancer 66 Heartburn Drugs 66 Eases Pain 66 Could Detect 66 R memantine HCl 66 Asthma Treatment 66 Treatment Naïve 66 Cholesterol Lowering 66 Inhaled Liposomal Ciprofloxacin 66 Kidney Transplant Recipients 66 Anti Tumor Activity 66 Long Lasting 66 Obesity Linked 66 Demonstrates Statistically Significant 66 Study Shows Promise 66 Announce Receipt 66 Therapy Reduces 66 Advisers Urge 66 Tablet Formulation 66 Slows Progression 66 Metformin HCl 66 Successfully Tested 65 Help Prevent 65 Researchers Develop 65 Investigational Drug 65 Stem Cell Treatment 65 Insulin Pen 65 Disease Modifying 65 Maleate 65 Mg Usa 65 Begin Clinical Trials 65 Launches Next Generation 65 Prophylactic Treatment 65 Study Identifies 65 Gene Variant 65 Guidelines Issued 65 Nears Completion 65 R famotidine 65 Orally Active 65 Mouse Model 65 Signs Exclusive 65 Statistically Significant 65 Receive Milestone Payment 65 VIVUS Announces 65 Oral Interferon 65 Warning Issued 65 Node Positive 65 Molecular Diagnostic Test 65 Collaborators Publish 65 Pave Way 65 Receptor Antagonist 65 Interferon Alpha 65 Therapeutic Competitors Companies 65 Clinical Efficacy 65 Introduces Innovative 65 Carboplatin Paclitaxel 65 Levoleucovorin 65 Improves Quality 65 Completes Successful 65 Overactive Bladder 65 Partial Onset Seizures 65 Treatment Regimen 65 Transdermal System 65 Announces Termination 65 Helps Reduce 65 Topical Treatment 65 Enters Into 65 Prolongs 65 Shown Effective 65 Improved Survival 65 Aztreonam Lysine 65 Contaminant Found 65 JAK Inhibitor 65 Grants Orphan Drug 65 Study Casts Doubt 65 Reacquires 65 Cardiovascular Events 65 Hydrochlorothiazide Tablets 65 Signs Agreements 65 Finalizes 65 Resistant Hypertension 65 Study Shows Benefits 65 Higher Doses 65 particularly SANCTURA XR 65 Unveils Latest 65 Earns Milestone Payment 65 Voluntarily Recalls 65 Kidney Function 65 Swine Flu Vaccine 65 Intravenous Formulation 65 Tumor Growth 65 Restricts Access 65 Silicone Breast Implants 65 Exercises Option 65 Widely Used 65 Chronic Hepatitis C 65 Being Tested 65 Kinase Inhibitor 65 Humanized Anti 65 Reduced Risk 65 Cypher Sirolimus 65 Reduces Mortality 65 Issues Guidance 65 Dose Ranging Study 65 Hormone Therapy 65 Nicotine Vaccine 65 Less Invasive 65 Lowers Blood Pressure 65 Guidelines Recommend 65 Announce Initiation 65 Premenopausal Women 65 Could Prevent 65 More Than Doubles 65 Study Compares 65 topical gel formulation 65 Halts Production 65 Non Invasive 65 Immune Cells 65 Human Monoclonal Antibody 65 Doctors Warn 65 Improve Survival 65 Potentially Deadly 65 Ovitrelle R Serostim 65 Could Revolutionize 65 Launches Unique 65 Relapsed Refractory 65 Renal Impairment 65 Generic Protonix 65 Treat Anemia 65 Cancer Treatments 64 Serious Side Effects 64 Refractory Hodgkin Lymphoma 64 Commercially Available 64 Intros 64 Debuts 64 Receives Favorable 64 Combination REOLYSIN R 64 ® chorionic gonadotropin 64 Clears Path 64 vapreotide acetate 64 Announces 64 Recombinant Human 64 Gene Mutation 64 Withdraws Application 64 Phase 2b Study 64 Announce Definitive Agreement 64 Acute Attacks 64 Could Become 64 Oral Fingolimod 64 Expands Capabilities 64 Announces Preliminary 64 NEBIDO VANTAS SUPPRELIN LA 64 Website Launched 64 Epoetin Alfa 64 Completes Patient Enrolment 64 Receives Marketing Authorization 64 Validates 64 Impotence Drug 64 Relaunches 64 Flu Vaccines 64 Efficacious 64 Knee Osteoarthritis 64 Drug Eluting 64 Renal Cell Carcinoma 64 Reports Preclinical Data 64 Help Detect 64 Disease Progression 64 Surgery Performed 64 Infected Patients 64 Jointly Announce 64 Advanced Pancreatic Cancer 64 Could Save Lives 64 Shares Surge 64 Settle Patent Litigation 64 Kidney Transplant Patients 64 Reconfirms 64 Vitrasert ® 64 Initiates Phase 2b 64 Peginterferon Alfa 2a 64 Subsidiary Receives 64 Platform Enables 64 Milestone Reached 64 Subsidiary Enters 64 Anti Nausea 64 Reduce Risk 64 Gears Up 64 Lung Cancer Patients 64 Enters Into Agreement 64 Receives 64 Abortion Pill 64 Nerve Pain 64 Adjuvant Therapy 64 Patient Treated 64 Confirms Efficacy 64 Oral Formulation 64 Speeds Up 64 Treated Patients 64 Treatment Shows Promise 64 Net Loss Narrows 64 Takes Delivery 64 Cancer Cells 64 Dramatically Increases 64 IND Filing 64 Valproic Acid 64 Study Evaluates 64 Inks Deal 64 Roche Boniva 64 Unleashes 64 Antidepressants Linked 64 Experts Urge 64 Completes 64 Prompts Recall 64 Approves 64 Cocaine Addiction 64 Peginterferon 64 Announces Immediate Availability 64 Completes Acquisition 64 Unfractionated Heparin 64 Therapeutic Efficacy 64 Phase 1b Clinical Trial 64 Study Validates 64 Vaccine Prevents 64 Potentially Fatal 64 Fentanyl Patch 64 Adjuvant Chemotherapy 64 Anticancer Activity 64 Announces Successful 64 Paves Way 64 Nasal Spray 64 Polymerase Inhibitor 64 Reach Agreement 64 Oral Spray 64 Agonist MABA program 64 Liver Damage 64 Melphalan 64 Reinvents 64 Efficacy Trial 64 Receives CE Marking 64 HCV Protease Inhibitor 64 Tumor Targeting 64 Gene Linked 64 Being Treated 64 Results Indicate 64 DIURIL R 64 benzoic acid hyoscyamine sulfate 64 Million Doses 64 Fortifies 64 Malaria Vaccine 64 Announces Filing 64 Disappoints 64 Novel Compounds 64 Patents Covering 64 Discount Cialis Cialis 64 Announces Signing 64 Immunosuppressant 64 Turned Into 64 Dose Escalation 64 Controlled Trial 64 Phase III Trials 63 Novel Compound 63 Beneficial Effects 63 Myeloma Patients 63 Combo Therapy 63 Vaccine Candidate 63 Derma Sciences Announces 63 Levels Linked 63 Hepatitis C Genotype 63 Diabetic Patients 63 Helps Ease 63 Breast Cancer Treatment 63 Submits Investigational 63 Extends Tender Offer 63 Prove Effective 63 Relapsing Multiple Sclerosis 63 Biogen Genentech 63 Offers Unique 63 Conjugate 63 First Patient Dosed 63 Completes Sale 63 Develops Novel 63 Helps Identify 63 Hemodialysis Patients 63 Multiple Myeloma Patients 63 Commences 63 Fast Tracked 63 Antifungal 63 Sinus Infections 63 Pivotal Trials 63 Could Trigger 63 Reduced Incidence 63 Announce Merger Agreement 63 Eszopiclone 63 Bosutinib 63 Expands Scope 63 Provides Comprehensive 63 Panel Urges 63 Treatment Naive Patients 63 Secures Funding 63 Positive Results 63 Report Examines 63 Ink Deal 63 Atypical Antipsychotic 63 Bazedoxifene 63 CHEAP ONLINE PHARMACY BEST 63 Smoking Linked 63 Hospital Acquired Pneumonia 63 Rheumatoid Arthritis Patients 63 Study Sheds Light 63 HER2 Positive Breast Cancer 63 Largest Ever 63 Readies 63 Completes Tender Offer 63 Could Predict 63 Announces Favorable 63 Expands Portfolio 63 Acquires 63 Strengthens Position 63 Greatly Reduces 63 approved incretin mimetic 63 Studies Suggest 63 Help Diagnose 63 Study Finds 63 Clinically Proven 63 Announce Settlement 63 Closes Sale 63 Readied 63 Aloxi ® 63 Protein Linked 63 Elicits 63 STELARA TM 63 Tezampanel 63 Report Analyzes 63 Erectile Dysfunction Drug 63 Cell Transplants 63 diarrhea fatigue asthenia 63 Metastatic Melanoma 63 Bronchodilator 63 Prodrug 63 Receives Notification 63 Opts 63 Announces Addition 63 Anti Tumor 63 Novel Antibiotic 63 Announce Completion 63 Confirmatory Phase 63 Study Concludes 63 Launches Enhanced 63 Statin Drugs 63 Announce Exclusive 63 Vaccine Shows Promise 63 Announces Expansion 63 Introduces Unique 63 Updates Guidance 63 Genes Associated 63 Acquire Assets 63 Blood Pressure Drugs 63 Lupus Nephritis 63 Brain Cells 63 Secondary Hyperparathyroidism 63 Dispenses 63 Q3 Loss Widens 63 Increased Mortality 63 Raises Awareness 63 Study Shows Significant 63 VIVITROL ® 63 Flu Vaccine 63 Tolerability 63 Blood Clots 63 Outperforms 63 Lung Cancer Trial 63 Successfully Complete 63 Extends Offer 63 Officially Launches 63 BUPHENYL ® sodium phenylbutyrate 63 First Patient Treated 63 Withdraws 63 Therapy Shows Promise 63 Helps Relieve 63 Extended Release Formulation 63 Drug Coated Stents 63 Recieves 63 Announces Acquisition 63 METOZOLV TM ODT metoclopramide 63 Device Helps 63 Dialysis Patients 63 Has Received 63 Attenuates 63 Licensing Deal 63 Deploys 63 Announces Expanded 63 Extends Reach 63 Carotid Stent 63 Changes Name 63 Haemophilus b Conjugate 63 Strongly Linked 63 Plummets 63 Scientists Identify 63 First Patient Enrolled 63 Signs Contract 63 oropharyngeal candidiasis OPC 63 Ondansetron Injection USP 63 Allergic Reactions 63 Significantly Reduce 63 Acetate Rectal Suppositories 63 pralatrexate injection folate analogue 63 Introduces Breakthrough 63 Statin Therapy 63 Pivotal Clinical Trial 63 Dry Powder Inhaler 63 Posaconazole 63 Being Evaluated 63 Launches Website 63 Causes Concern 63 Resubmission 63 Acute Migraine 63 Receives Conditional 63 Blood Vessel 63 Small Molecule 63 Predict Risk 63 Novel Method 63 Secures Financing 63 CHEAP ONLINE PHARMACY LOW 63 FDA Approves Expanded 63 Zorbtive TM 63 Inadequately Controlled 63 Deemed Safe 63 Shows Statistically Significant 63 Oral Cladribine 63 Drug Prevents 63 Pre Cancerous 63 Arthritis Sufferers 63 Reaches Milestone 63 Eradicates 63 Voluntary Recall 63 Unveils Next Generation 63 Be Treated 63 Phase IIa Trial 63 Therapy Helps 63 Plays Role 63 Impairs 63 Estrogen Therapy 63 Helps Predict 63 Dosed 63 Issues Warning 63 Microdermabrasion Chemical Peels Collagen 63 liver resection surgeries 63 Dose Escalation Study 63 Unveils Revolutionary 63 Immunomedics Announces 63 Succumbs 63 Provide Comprehensive 63 markets XIFAXAN ® 63 R Saizen R 63 Topical Gel 62 Pharmaceuticals Initiates 62 PDUFA Date 62 Announces Dismissal 62 Further Validates 62 Shares Soar 62 Demonstrates Sustained 62 Regenerative Cells 62 Migraine Treatment 62 Reinforces 62 Elevates 62 Panel Advises 62 Advanced Gastric Cancer 62 Report Indicates 62 Influenza Vaccine 62 NOTE POSIDUR ™ 62 Menopausal Symptoms 62 Redefines 62 Pafuramidine 62 Bodes Well 62 Be Studied 62 Be Tested 62 Phase III Pivotal Trial 62 Capsules CII 62 ® adefovir dipivoxil 62 Inks Licensing Deal 62 Genetically Engineered Salmon 62 Ondansetron Orally Disintegrating Tablets 62 Regains Full 62 Lawsuit Filed Over 62 Univest Corporation Declares 62 Trial Halted 62 Testosterone Patch 62 Confirms 62 R lenalidomide 62 Moves Towards 62 Companion Diagnostic 62 Eliminates Need 62 Breaks Ground 62 Resubmit 62 Nasal Powder 62 Newly Identified 62 Obtains CE Mark 62 Enlarged Prostate 62 Announce Licensing 62 Could Harm 62 Refocuses 62 Help Predict 62 Satisfies 62 Combats 62 Reach Settlement 62 Maker Sues 62 Pose Risk 62 Antibiotic Use 62 Enters Into Exclusive 62 Lower Blood Pressure 62 Allergy Sufferers 62 Establish Joint Venture 62 Net Loss Widens 62 Draws Attention 62 Vaccine Protects Against 62 Invents 62 Fracture Risk 62 Benign Prostatic Hyperplasia 62 Reaffirms Commitment 62 Secures 62 FDA Cracks Down 62 Approve Merger 62 Patient Enrolment 62 Cranks Out 62 Makes Debut 62 Vildagliptin 62 Pain Medications 62 Heightens 62 R MSCRAMM 62 Integrase Inhibitor 62 Provides Update Regarding 62 Flagship Product 62 Q1 Loss Widens 62 Androgen Deprivation Therapy 62 Files Registration Statement 62 Inks Agreement 62 Dedicates 62 Inks Deal With 62 Subgroup Analysis 62 Vascular Grafts 62 Transplant Patients 62 Resolve Dispute 62 Moves Into 62 Recovers From 62 Long Awaited 62 Liver Metastases 62 Could Mean 62 Virus Linked 62 Reopens 62 Reports Receipt 62 Potent Antiviral Activity 62 Signs Agreement 62 Drug Eluting Stent 62 Awarded Qualifying Therapeutic 62 Decongestant 62 Helps Detect 62 Expand Relationship 62 Sublingual 62 Non Invasive Treatment 62 administered concomitantly 62 Prolongs Life 62 Moves Forward 62 Quadruples 62 Retracts 62 RNAi Therapeutic 62 Identifies Potential 62 Inaugurates 62 Expands Availability 62 Antipsychotic Drugs 62 Acquires Assets 62 SPRYCEL ® 62 Provides Updates 62 Zoledronic Acid 62 Merck OSI Pharmaceuticals 62 TM Drug Eluting 62 Inhaled Nitric Oxide 62 Gets Makeover 62 Awarded Contract 62 Sirolimus Eluting 62 Halts 62 Signs Deal 62 Transdermal Drug 62 Premature Infants 62 Viral Load 62 Outsells 62 Meningitis Vaccine 62 Opens Door 62 Relapsed Multiple Myeloma 62 Starts Shipping 62 Amplifies 62 Abdominal Pain 62 Placebo Controlled Trial 62 Horizant ™ 62 Settlement Reached 62 Stock Soars 62 Eases 62 Strengthens Its 62 Terminate Merger Agreement 62 Achieves Highest 62 Announces Formation 62 Releases Next Generation 62 Abandons Plans 62 Anti Inflammatory Drug 62 Orally Disintegrating 62 Experts Warn 62 Prospective Randomized 62 Obese Patients 62 Regains Compliance 62 Caution Urged